Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Retinoblastoma × Topotecan × Clear all

Phase

Status

Completed 5 Recruiting 3 Withdrawn 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Ovarian Neoplasms 19 Small Cell Lung Carcinoma 9 Carcinoma, Ovarian Epithelial 8 Fallopian Tube Neoplasms 7 Recurrence 6 Brain Neoplasms 5 Neuroblastoma 4 Neoplasms 4 Lung Neoplasms 4 Medulloblastoma 3 Glioma 3 Central Nervous System Neoplasms 3 Uterine Cervical Neoplasms 2 Rhabdoid Tumor 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasm Metastasis 2 Meningeal Carcinomatosis 2 Familial ependymoma 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Astrocytoma 2 Unspecified Childhood Solid Tumor, Protocol Specific 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Triple Negative Breast Neoplasms 1 Sarcoma 1 Rhabdomyosarcoma 1 Retinoblastoma 1 Optic Nerve Glioma 1 Oligodendroglioma 1

Interventions

Melphalan 6 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Thiotepa 2 Etoposide 2 Busulfan 2 sargramostim 1 Vincristine 1 Topotecan 1 Temozolomide 1 Stem Cell Transplantation 1 Radiotherapy, Intensity-Modulated 1 Proton Therapy 1 Peripheral Blood Stem Cell Transplantation 1 Mesna 1 Ifosfamide 1 Carboplatin 1 Bone Marrow Transplantation 1 Amifostine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04455139 2023-10-03

EuRbG2018

University of Lausanne Hospitals

Phase 2 Terminated

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡